SMAD4 and hereditary hemorrhagic telangiectasia: SMAD4 is canonically associated with TAAD in individuals with a concurrent diagnosis of juvenile polyposis syndrome (JPS), hereditary hemorrhagic telangiectasia (HHT), or combined JPS-HHT[65–67].